Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Nov 1;100(9):2227–2234. doi: 10.1172/JCI119760

HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis.

D S Bradley 1, G H Nabozny 1, S Cheng 1, P Zhou 1, M M Griffiths 1, H S Luthra 1, C S David 1
PMCID: PMC508418  PMID: 9410900

Abstract

Certain HLA-DR alleles have been associated with predisposition to human rheumatoid arthritis (RA). There is also evidence that certain HLA-DQ alleles may also be important in determining susceptibility to RA. We have previously demonstrated that mice transgenic for HLA-DQ8, a DQ allele associated with susceptibility to RA, develop severe arthritis after type II collagen immunization. To investigate the influence of polymorphic difference at the DQ loci on susceptibility to arthritis, we generated mice transgenic for HLA-DQ6, an allele associated with a nonsusceptible haplotype. The DQ6 mice were found to be resistant to collagen-induced arthritis. We also assessed the combined effect of an RA-susceptible and an RA nonassociated DQ allele by producing double-transgenic mice expressing DQ6 and DQ8 molecules, representing the more prevalent condition found in humans where heterozygosity at the DQ allele is common. The double-transgenic mice developed moderate CIA when immunized with CII when compared with the severe arthritis observed in DQ8 transgenic mice, much like RA patients bearing both susceptible and nonsusceptible HLA haplotypes. These studies support a role for HLA-DQ polymorphism in human RA.

Full Text

The Full Text of this article is available as a PDF (267.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acha-Orbea H., Zinkernagel R. M., Hengartner H. Cytotoxic T cell clone-specific monoclonal antibodies used to select clonotypic antigen-specific cytotoxic T cells. Eur J Immunol. 1985 Jan;15(1):31–36. doi: 10.1002/eji.1830150107. [DOI] [PubMed] [Google Scholar]
  2. Arnett F. C., Bias W. B., Reveille J. D. Genetic studies in Sjögren's syndrome and systemic lupus erythematosus. J Autoimmun. 1989 Aug;2(4):403–413. doi: 10.1016/0896-8411(89)90169-8. [DOI] [PubMed] [Google Scholar]
  3. Arnett F. C., Reveille J. D. Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am. 1992 Nov;18(4):865–892. [PubMed] [Google Scholar]
  4. Auger I., Roudier J. A function for the QKRAA amino acid motif: mediating binding of DnaJ to DnaK. Implications for the association of rheumatoid arthritis with HLA-DR4. J Clin Invest. 1997 Apr 15;99(8):1818–1822. doi: 10.1172/JCI119348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Badenhoop K. Immunogenetic markers for autoimmune diseases of the endocrine system. Klin Wochenschr. 1990;68 (Suppl 21):10–14. [PubMed] [Google Scholar]
  6. Baisch J. M., Weeks T., Giles R., Hoover M., Stastny P., Capra J. D. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med. 1990 Jun 28;322(26):1836–1841. doi: 10.1056/NEJM199006283222602. [DOI] [PubMed] [Google Scholar]
  7. Beck B. N., Buerstedde J. M., Krco C. J., Nilson A. E., Chase C. G., McKean D. J. Characterization of cell lines expressing mutant I-Ab and I-Ak molecules allows the definition of distinct serologic epitopes on A alpha and A beta polypeptides. J Immunol. 1986 Apr 15;136(8):2953–2961. [PubMed] [Google Scholar]
  8. Begovich A. B., McClure G. R., Suraj V. C., Helmuth R. C., Fildes N., Bugawan T. L., Erlich H. A., Klitz W. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol. 1992 Jan 1;148(1):249–258. [PubMed] [Google Scholar]
  9. Bell J., Rassenti L., Smoot S., Smith K., Newby C., Hohlfeld R., Toyka K., McDevitt H., Steinman L. HLA-DQ beta-chain polymorphism linked to myasthenia gravis. Lancet. 1986 May 10;1(8489):1058–1060. doi: 10.1016/s0140-6736(86)91330-9. [DOI] [PubMed] [Google Scholar]
  10. Bill J., Kanagawa O., Woodland D. L., Palmer E. The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells. J Exp Med. 1989 Apr 1;169(4):1405–1419. doi: 10.1084/jem.169.4.1405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chaplin D. D., Kemp M. E. The major histocompatibility complex and autoimmunity. Year Immunol. 1988;3:179–198. [PubMed] [Google Scholar]
  12. Chicz R. M., Lane W. S., Robinson R. A., Trucco M., Strominger J. L., Gorga J. C. Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. Int Immunol. 1994 Nov;6(11):1639–1649. doi: 10.1093/intimm/6.11.1639. [DOI] [PubMed] [Google Scholar]
  13. Christiansen F. T., Zhang W. J., Griffiths M., Mallal S. A., Dawkins R. L. Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus (SLE): C4 deficiency explains some but not all of the influence of the MHC. J Rheumatol. 1991 Sep;18(9):1350–1358. [PubMed] [Google Scholar]
  14. Cosgrove D., Gray D., Dierich A., Kaufman J., Lemeur M., Benoist C., Mathis D. Mice lacking MHC class II molecules. Cell. 1991 Sep 6;66(5):1051–1066. doi: 10.1016/0092-8674(91)90448-8. [DOI] [PubMed] [Google Scholar]
  15. Deighton C. M., Cavanagh G., Rigby A. S., Lloyd H. L., Walker D. J. Both inherited HLA-haplotypes are important in the predisposition to rheumatoid arthritis. Br J Rheumatol. 1993 Oct;32(10):893–898. doi: 10.1093/rheumatology/32.10.893. [DOI] [PubMed] [Google Scholar]
  16. Farid N. R., Thompson C. HLA and autoimmune endocrine disease 1985. Mol Biol Med. 1986 Feb;3(1):85–97. [PubMed] [Google Scholar]
  17. Giles R. C., Nunez G., Hurley C. K., Nunez-Roldan A., Winchester R., Stastny P., Capra J. D. Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. J Exp Med. 1983 May 1;157(5):1461–1470. doi: 10.1084/jem.157.5.1461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Goldstein R., Arnett F. C. The genetics of rheumatic disease in man. Rheum Dis Clin North Am. 1987 Dec;13(3):487–510. [PubMed] [Google Scholar]
  19. Gonzalez-Gay M. A., Zanelli E., Khare S. D., Krco C. J., Zhou P., Inoko H., Griffiths M. M., Luthra H. S., David C. S. Human leukocyte antigen-DRB1*1502 (DR2Dw12) transgene reduces incidence and severity of arthritis in mice. Hum Immunol. 1996 Sep 15;50(1):54–60. doi: 10.1016/0198-8859(96)00123-1. [DOI] [PubMed] [Google Scholar]
  20. Gregersen P. K., Shen M., Song Q. L., Merryman P., Degar S., Seki T., Maccari J., Goldberg D., Murphy H., Schwenzer J. Molecular diversity of HLA-DR4 haplotypes. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2642–2646. doi: 10.1073/pnas.83.8.2642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gregersen P. K., Silver J., Winchester R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987 Nov;30(11):1205–1213. doi: 10.1002/art.1780301102. [DOI] [PubMed] [Google Scholar]
  22. Griffiths M. M., Eichwald E. J., Martin J. H., Smith C. B., DeWitt C. W. Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arthritis Rheum. 1981 Jun;24(6):781–789. doi: 10.1002/art.1780240605. [DOI] [PubMed] [Google Scholar]
  23. Griffiths M. M., Nabozny G. H., Hanson J., Harper D. S., McCall S., Moder K. G., Cannon G. W., Luthra H. S., David C. S. Collagen-induced arthritis and TCRs in SWR and B10.Q mice expressing an Ek alpha transgene. J Immunol. 1994 Sep 15;153(6):2758–2768. [PubMed] [Google Scholar]
  24. Grégoire C., Rebaï N., Schweisguth F., Necker A., Mazza G., Auphan N., Millward A., Schmitt-Verhulst A. M., Malissen B. Engineered secreted T-cell receptor alpha beta heterodimers. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8077–8081. doi: 10.1073/pnas.88.18.8077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Harley J. B., Reichlin M., Arnett F. C., Alexander E. L., Bias W. B., Provost T. T. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science. 1986 May 30;232(4754):1145–1147. doi: 10.1126/science.3458307. [DOI] [PubMed] [Google Scholar]
  26. Haskins K., Hannum C., White J., Roehm N., Kubo R., Kappler J., Marrack P. The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype. J Exp Med. 1984 Aug 1;160(2):452–471. doi: 10.1084/jem.160.2.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kanagawa O., Utsunomiya Y., Bill J., Palmer E., Moore M. W., Carbone F. R. Conformational difference of T cell antigen receptors revealed by monoclonal antibodies to mouse V beta 5 T cell receptor for antigen determinants. J Immunol. 1991 Aug 15;147(4):1307–1314. [PubMed] [Google Scholar]
  28. Kappler J. W., Roehm N., Marrack P. T cell tolerance by clonal elimination in the thymus. Cell. 1987 Apr 24;49(2):273–280. doi: 10.1016/0092-8674(87)90568-x. [DOI] [PubMed] [Google Scholar]
  29. Kappler J. W., Staerz U., White J., Marrack P. C. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature. 1988 Mar 3;332(6159):35–40. doi: 10.1038/332035a0. [DOI] [PubMed] [Google Scholar]
  30. Lampson L. A., Levy R. Two populations of Ia-like molecules on a human B cell line. J Immunol. 1980 Jul;125(1):293–299. [PubMed] [Google Scholar]
  31. Lanchbury J. S., Sakkas L. I., Marsh S. G., Bodmer J. G., Welsh K. I., Panayi G. S. HLA-DQ beta 3.1 allele is a determinant of susceptibility to DR4-associated rheumatoid arthritis. Hum Immunol. 1989 Sep;26(1):59–71. doi: 10.1016/0198-8859(89)90033-5. [DOI] [PubMed] [Google Scholar]
  32. Lerner E. A., Matis L. A., Janeway C. A., Jr, Jones P. P., Schwartz R. H., Murphy D. B. Monoclonal antibody against an Ir gene product? J Exp Med. 1980 Oct 1;152(4):1085–1101. doi: 10.1084/jem.152.4.1085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Liao N. S., Maltzman J., Raulet D. H. Positive selection determines T cell receptor V beta 14 gene usage by CD8+ T cells. J Exp Med. 1989 Jul 1;170(1):135–143. doi: 10.1084/jem.170.1.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Maclaren N. K., Riley W. J. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type I autoimmune polyglandular syndrome. J Clin Endocrinol Metab. 1986 Mar;62(3):455–459. doi: 10.1210/jcem-62-3-455. [DOI] [PubMed] [Google Scholar]
  35. Nabozny G. H., Baisch J. M., Cheng S., Cosgrove D., Griffiths M. M., Luthra H. S., David C. S. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med. 1996 Jan 1;183(1):27–37. doi: 10.1084/jem.183.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Nepom G. T. Determinants of genetic susceptibility in HLA-associated autoimmune disease. Clin Immunol Immunopathol. 1989 Nov;53(2 Pt 2):S53–S62. doi: 10.1016/0090-1229(89)90070-6. [DOI] [PubMed] [Google Scholar]
  37. Nepom G. T., Erlich H. MHC class-II molecules and autoimmunity. Annu Rev Immunol. 1991;9:493–525. doi: 10.1146/annurev.iy.09.040191.002425. [DOI] [PubMed] [Google Scholar]
  38. Okada C. Y., Holzmann B., Guidos C., Palmer E., Weissman I. L. Characterization of a rat monoclonal antibody specific for a determinant encoded by the V beta 7 gene segment. Depletion of V beta 7+ T cells in mice with Mls-1a haplotype. J Immunol. 1990 May 1;144(9):3473–3477. [PubMed] [Google Scholar]
  39. Okada K., Boss J. M., Prentice H., Spies T., Mengler R., Auffray C., Lillie J., Grossberger D., Strominger J. L. Gene organization of DC and DX subregions of the human major histocompatibility complex. Proc Natl Acad Sci U S A. 1985 May;82(10):3410–3414. doi: 10.1073/pnas.82.10.3410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Oksenberg J. R., Begovich A. B., Erlich H. A., Steinman L. Genetic factors in multiple sclerosis. JAMA. 1993 Nov 17;270(19):2362–2369. [PubMed] [Google Scholar]
  41. Ollier W., Thomson W. Population genetics of rheumatoid arthritis. Rheum Dis Clin North Am. 1992 Nov;18(4):741–759. [PubMed] [Google Scholar]
  42. Sattar M. A., al-Saffar M., Guindi R. T., Sugathan T. N., Behbehani K. Association between HLA-DR antigens and rheumatoid arthritis in Arabs. Ann Rheum Dis. 1990 Mar;49(3):147–149. doi: 10.1136/ard.49.3.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Singal D. P., D'Souza M., Reid B., Bensen W. G., Kassam Y. B., Adachi J. D. HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritis. Lancet. 1987 Nov 14;2(8568):1118–1120. doi: 10.1016/s0140-6736(87)91548-0. [DOI] [PubMed] [Google Scholar]
  44. Skanes V. M., Barnard J., Farid N., Marshall W. H., Murphy L., Rideout D., Taylor R., Xidos G., Larsen B. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis. Mol Biol Med. 1986 Apr;3(2):143–157. [PubMed] [Google Scholar]
  45. Skarsvåg S., Hansen K. E., Holst A., Moen T. Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non[DRB1*03,DQA1*0501,DQB1*0201] class II homozygotes? Tissue Antigens. 1992 Sep;40(3):128–133. doi: 10.1111/j.1399-0039.1992.tb02104.x. [DOI] [PubMed] [Google Scholar]
  46. Staerz U. D., Rammensee H. G., Benedetto J. D., Bevan M. J. Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. J Immunol. 1985 Jun;134(6):3994–4000. [PubMed] [Google Scholar]
  47. Stuart J. M., Huffstutter E. H., Townes A. S., Kang A. H. Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by 125I-radioimmunoassay. Arthritis Rheum. 1983 Jul;26(7):832–840. doi: 10.1002/art.1780260703. [DOI] [PubMed] [Google Scholar]
  48. Stuart J. M., Townes A. S., Kang A. H. Collagen autoimmune arthritis. Annu Rev Immunol. 1984;2:199–218. doi: 10.1146/annurev.iy.02.040184.001215. [DOI] [PubMed] [Google Scholar]
  49. Taneja V., Mehra N. K., Chandershekaran A. N., Ahuja R. K., Singh Y. N., Malaviya A. N. HLA-DR4-DQw8, but not DR4-DQw7 haplotypes occur in Indian patients with rheumatoid arthritis. Rheumatol Int. 1992;11(6):251–255. doi: 10.1007/BF00301502. [DOI] [PubMed] [Google Scholar]
  50. Todd J. A., Bell J. I., McDevitt H. O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 1987 Oct 15;329(6140):599–604. doi: 10.1038/329599a0. [DOI] [PubMed] [Google Scholar]
  51. Tomonari K., Lovering E., Spencer S. Correlation between the V beta 4+ CD8+ T-cell population and the H-2d haplotype. Immunogenetics. 1990;31(5-6):333–339. doi: 10.1007/BF02115007. [DOI] [PubMed] [Google Scholar]
  52. Torfs C. P., King M. C., Huey B., Malmgren J., Grumet F. C. Genetic interrelationship between insulin-dependent diabetes mellitus, the autoimmune thyroid diseases, and rheumatoid arthritis. Am J Hum Genet. 1986 Feb;38(2):170–187. [PMC free article] [PubMed] [Google Scholar]
  53. Trentham D. E. Collagen arthritis as a relevant model for rheumatoid arthritis. Arthritis Rheum. 1982 Aug;25(8):911–916. doi: 10.1002/art.1780250801. [DOI] [PubMed] [Google Scholar]
  54. Trentham D. E., Kammer G. M., McCune W. J., David J. R. Autoimmunity to collagen: a shared feature of psoriatic and rheumatoid arthritis. Arthritis Rheum. 1981 Nov;24(11):1363–1369. doi: 10.1002/art.1780241105. [DOI] [PubMed] [Google Scholar]
  55. Trentham D. E., Townes A. S., Kang A. H. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med. 1977 Sep 1;146(3):857–868. doi: 10.1084/jem.146.3.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Vogt A. B., Kropshofer H., Kalbacher H., Kalbus M., Rammensee H. G., Coligan J. E., Martin R. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J Immunol. 1994 Aug 15;153(4):1665–1673. [PubMed] [Google Scholar]
  57. Weyand C. M., Hicok K. C., Conn D. L., Goronzy J. J. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med. 1992 Nov 15;117(10):801–806. doi: 10.7326/0003-4819-117-10-801. [DOI] [PubMed] [Google Scholar]
  58. Willkens R. F., Nepom G. T., Marks C. R., Nettles J. W., Nepom B. S. Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the "shared epitope" hypothesis. Arthritis Rheum. 1991 Jan;34(1):43–47. doi: 10.1002/art.1780340107. [DOI] [PubMed] [Google Scholar]
  59. Wilson C., Ebringer A., Ahmadi K., Wrigglesworth J., Tiwana H., Fielder M., Binder A., Ettelaie C., Cunningham P., Joannou C. Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis. Ann Rheum Dis. 1995 Mar;54(3):216–220. doi: 10.1136/ard.54.3.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Winchester R., Dwyer E., Rose S. The genetic basis of rheumatoid arthritis. The shared epitope hypothesis. Rheum Dis Clin North Am. 1992 Nov;18(4):761–783. [PubMed] [Google Scholar]
  61. Wooley P. H., Luthra H. S., Stuart J. M., David C. S. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med. 1981 Sep 1;154(3):688–700. doi: 10.1084/jem.154.3.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Wordsworth B. P., Lanchbury J. S., Sakkas L. I., Welsh K. I., Panayi G. S., Bell J. I. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci U S A. 1989 Dec;86(24):10049–10053. doi: 10.1073/pnas.86.24.10049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Wordsworth P., Pile K. D., Buckely J. D., Lanchbury J. S., Ollier B., Lathrop M., Bell J. I. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet. 1992 Sep;51(3):585–591. [PMC free article] [PubMed] [Google Scholar]
  64. Yelamos J., Garcia-Lozano J. R., Moreno I., Aguilera I., Gonzalez M. F., Garcia A., Nuñez-Roldan A., Sanchez B. Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum. 1993 Jun;36(6):811–814. doi: 10.1002/art.1780360611. [DOI] [PubMed] [Google Scholar]
  65. Yoo T. J., Kim S. Y., Stuart J. M., Floyd R. A., Olson G. A., Cremer M. A., Kang A. H. Induction of arthritis in monkeys by immunization with type II collagen. J Exp Med. 1988 Aug 1;168(2):777–782. doi: 10.1084/jem.168.2.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Zanelli E., Krco C. J., Baisch J. M., Cheng S., David C. S. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1814–1819. doi: 10.1073/pnas.93.5.1814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Zanelli E., Krco C. J., David C. S. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition. J Immunol. 1997 Apr 1;158(7):3545–3551. [PubMed] [Google Scholar]
  68. Zhou P., Anderson G. D., Savarirayan S., Inoko H., David C. S. Thymic deletion of V beta 11+, V beta 5+ T cells in H-2E negative, HLA-DQ beta+ single transgenic mice. J Immunol. 1991 Feb 1;146(3):854–859. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES